- Details
- Description
Mounjaro 10 mg KwikPen is a prescription, once-weekly injectable medicine containing tirzepatide, a GIP and GLP-1 receptor agonist. It is used to help improve blood-glucose control in type 2 diabetes and, where approved, to support weight management alongside appropriate diet and physical activity. Each dose contains 10 mg of tirzepatide in 0.6 mL, and each multi-dose KwikPen provides 4 weekly doses, containing 40 mg of tirzepatide in total.
Active substance: Tirzepatide
Strength: 10 mg/0.6 mL per dose
Dosage form: Solution for subcutaneous injection
Pack: 1 multi-dose pre-filled KwikPen containing 4 doses.
Pack contents: One KwikPen contains 40 mg of tirzepatide in 2.4 mL and delivers 4 doses of 10 mg. Needles are not included in the pack.
Manufacturer/origin: The approved manufacturing network includes sites in Italy, Spain, France, and Ireland. The exact origin should be taken from the specific package/batch.
